Masaomi Gohbara

Dr. Masaomi Gohbara


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2015 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
KOKozo Okada
Kozo Okada
KHKiyoshi Hibi
Kiyoshi Hibi
MGMasaomi Gohbara
Masaomi Gohbara
SKShunsuke Kataoka
Shunsuke Kataoka
KTKeiko Takano
Keiko Takano
KKKazuo Kimura
Kazuo Kimura
Blood glucose variability is receiving considerable attention as a new risk factor for coronary artery disease. This study aimed to investigate the association between blood glucose variability and coronary plaque tissue characteristics. In 57 patients with acute coronary syndrome, integrated backscatter intravascular ultrasound (IB-IVUS) and gray-scale IVUS were performed before balloon dilatation or stent implantation in the culprit vessels. Standard IVUS indices were evaluated for volume index (volume/length), and plaque components were measured by IB-IVUS for percent tissue volume. In addition to conventional glucose indicators, blood glucose variability in a stable state was determined by calculating the mean amplitude of glycemic excursions (MAGE) using a continuous glucose monitoring system. Higher MAGE values were significantly correlated with larger percent plaque volumes (r = 0.32, p = 0.015), and increased lipid (r = 0.44, p = 0.0006) and decreased fibrous (r = −0.45, p = 0.0005) plaque components. In contrast, HbA1c or fasting plasma glucose values were not significantly correlated with plaque volumes and percent plaque components. Homeostasis model assessment of insulin resistance values were positively correlated with vessel (r = 0.35, p = 0.007) and plaque (r = 0.27, p = 0.046) volumes, but not with percent plaque components. In multiple regression analysis, higher MAGE values were independently associated with increased lipid (β = 0.80, p = 0.0035) and decreased fibrous (β = -0.79, p = 0.0034) contents in coronary plaques. Among all glucose indicators studied, only higher blood glucose variability was an independent determinant of increased lipid and decreased fibrous contents with larger plaque burden, suggesting blood glucose variability as one of the important factors related to coronary plaque vulnerability.

18 August 2018 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
HTHironori Takahashi
Hironori Takahashi
NINoriaki Iwahashi
Noriaki Iwahashi
JKJin Kirigaya
Jin Kirigaya
SKShunsuke Kataoka
Shunsuke Kataoka
YMYugo Minamimoto
Yugo Minamimoto
KKKazuo Kimura
Kazuo Kimura
Impaired glucose metabolism is an established risk factor for coronary artery disease. Previous studies revealed that glycemic variability (GV) is also important for glucose metabolism in patients with acute coronary syndrome (ACS). We explored the association between GV and prognosis in patients with ACS. A total of 417 patients with ACS who received reperfusion wore a continuous glucose monitoring system (CGMS) in a stable phase after admission and were monitored for at least 24 consecutive h. The mean amplitude of glycemic excursion (MAGE) was calculated as a marker of GV. We divided into two groups based on the highest tertile levels of MAGE (MAGE = 52 mg/dl). The groups were followed up for a median of 39 months [IQR 24–50 months]. The primary endpoint was the incidence of major adverse cardiovascular and cerebrovascular events (MACCE). During follow-up, 66 patients experienced MACCE (5 patients had cardiovascular death, 14 had recurrence of ACS, 27 had angina requiring revascularization, 8 had acute decompensated heart failure, and 16 had a stroke). MACCE was more frequently observed in the high MAGE group (23.5% vs. 11.6%, p = 0.002). In multivariate analysis, high MAGE was an independent predictive factor of poor prognosis for MACCE (odds ratio, 1.84; 95% confidence interval, 1.01–3.36; p = 0.045). Glycemic variability determined with a CGMS is a predictor of prognosis in patients with ACS without severe DM. Trial registration UMIN 000010620. Registered April 1st 2012

1 January 2015 in Circulation Journal
Verified
Journal Article
Closed access
SKShunsuke Kataoka
Shunsuke Kataoka
MGMasaomi Gohbara
Masaomi Gohbara
NINoriaki Iwahashi
Noriaki Iwahashi
KSKentaro Sakamaki
Kentaro Sakamaki
TNTatsuya Nakachi
Tatsuya Nakachi
KKKazuo Kimura
Kazuo Kimura
MAGE early after the onset of ACS is a predictor of RP of non-culprit lesions.

2 August 2017 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
MGMasaomi Gohbara
Masaomi Gohbara
AHAzusa Hayakawa
Azusa Hayakawa
YAYusuke Akazawa
Yusuke Akazawa
SFShuta Furihata
Shuta Furihata
AKAi Kondo
Ai Kondo
KTKouichi Tamura
Kouichi Tamura
Background: Contrast‐induced nephropathy ( CIN ) is associated with poor outcomes in patients with acute myocardial infarction. However, the predictors of CIN have yet to be fully elucidated. Methods and Results: The study included 273 consecutive patients with a first‐time ST ‐segment elevation myocardial infarction who underwent reperfusion within 12 hours of symptom onset. The exclusion criteria were hemodialysis, mechanical ventilation, or previous coronary artery bypass grafting. All patients underwent arterial blood gas analysis soon after reperfusion. CIN was defined as an increase of 0.5 mg/dL in serum creatinine or a 25% increase from baseline between 48 and 72 hours after contrast medium exposure. Acidosis was defined as an arterial blood pH <7.35. CIN was observed in 35 patients (12.8%). Multivariable logistic regression analysis with forward stepwise algorithm revealed a significant association between CIN and the following: reperfusion time, the prevalence of hypertension, peak creatine kinase‐ MB , high‐sensitivity C‐reactive protein on admission, and the incidence of acidosis ( P <0.05). Multivariable logistic regression analysis revealed that the incidence of acidosis was associated with CIN when adjusted for age, male sex, body mass index, amount of contrast medium used, estimated glomerular filtration rate on admission, glucose level on admission, high‐sensitivity C‐reactive protein on admission, and left ventricular ejection fraction ( P <0.05). Moreover, the incidence of acidosis was associated with CIN when adjusted for the Mehran CIN risk score (odds ratio: 2.229, P =0.049). Conclusions: The incidence of acidosis soon after reperfusion was associated with CIN in patients with a first‐time ST ‐segment elevation myocardial infarction.

1 November 2016 in Journal of Cardiology
Verified
Journal Article
Closed access
MGMasaomi Gohbara
Masaomi Gohbara
NINoriaki Iwahashi
Noriaki Iwahashi
EAEiichi Akiyama
Eiichi Akiyama
NMNobuhiko Maejima
Nobuhiko Maejima
KTKengo Tsukahara
Kengo Tsukahara
KKKazuo Kimura
Kazuo Kimura

10 January 2019 in Circulation Reports
Verified
Journal Article
Open access
PDF file
MGMasaomi Gohbara
Masaomi Gohbara
KNKunihiro Nishimura
Kunihiro Nishimura
MNMichikazu Nakai
Michikazu Nakai
YSYoko Sumita
Yoko Sumita
TETsutomu Endo
Tsutomu Endo
KKKazuo Kimura
Kazuo Kimura
Background: The aim of this study was to clarify the clinical impact of activities of daily living (ADL) using the Japanese Registry of All Cardiac and Vascular Diseases-Diagnosis Procedure Combination (JROAD-DPC) database. Methods and Results: From April 2012 to March 2014, the JROAD-DPC database included 206,643 patients with acute coronary syndrome (ACS; n=49,784), heart failure (HF; n=136,878), or aortic aneurysm/dissection (Aorta; n=19,981). We divided them into 3 categories with regard to age (low, 20–59 years; middle, 60–79 years; high, ≥80 years) and admission ADL (low, Barthel index [BI] 0–70; middle, BI 75–95; high, BI 100). ACS, HF, and Aorta patients with low ADL had higher in-hospital mortality rates (18.3%, 16.7%, and 33.4%) than those with middle or high ADL (P<0.001, χ2 test). On multivariable analysis, BI on admission was associated with in-hospital mortality of ACS (OR, 0.986 per 1 BI; P<0.001), HF (OR, 0.986 per 1 BI; P<0.001), and Aorta (OR, 0.986 per 1 BI; P<0.001), adjusted for gender, age, body mass index, hypertension, diabetes mellitus, dyslipidemia, and the Charlson comorbidity index. Moreover, patients with low age and low ADL had a higher in-hospital mortality rate than those with high age and high ADL in regard to HF (8.6% vs. 6.0%). Conclusions: According to JROAD-DPC data, assessment of admission ADL is important in patients with cardiovascular disease.